Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SIDI could be useful for NDIs

This article was originally published in The Tan Sheet

Executive Summary

FDA expects the Standardized Information on Dietary Ingredients program to be a "valuable tool" for collecting new dietary ingredient notification information, Council for Responsible Nutrition VP for Scientific and Regulatory Affairs Andrew Shao tells supplement industry executives at CRN's annual conference Oct. 4. FDA's Center for Food Safety and Applied Nutrition director of dietary supplement programs, Bill Frankos, told CRN it provides the "same type of information that FDA looks for in those notifications that they never get." In his presentation, Shao provided an overview of SIDI, a voluntary program established by supplement industry trade groups in October 2006 to simplify and standardize the exchange of information between ingredient suppliers and product manufacturers (1"The Tan Sheet" Oct. 23, 2006, p. 8). CFSAN Director Robert E. Brackett stated NDIs marketed without undergoing the NDI notification process is one of the agency's top concerns...

You may also be interested in...

SIDI Program Will Standardize Ingredient Protocol – Supplement Trade Groups

A voluntary protocol could prompt "a major paradigm shift for many in the [dietary supplement] industry by moving away from unique individualized questionnaires towards standardized documentation and information exchange," trade groups say

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts